UAE Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

UAE Biomaterials in Healthcare Market Analysis

$ 3999

The UAE Biomaterials in Healthcare Market is expected to witness growth from $781 Mn Bn in 2022 to $2260 Mn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. The demand for biomaterials, is rising in UAE as the population increases. As a result, there are now chances for manufacturers of biomaterials to diversify their product lines and grow their market share. The market is segmented by type and by application. Some key players in this market include: Julphar, Mena Medical Supplies, Mena Medical Supplies, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10AEMD003 CATEGORY: Medical Devices GEOGRAPHY: UAE AUTHOR: Jigyasu Bhandari

Buy Now

UAE Biomaterials in Healthcare Market Executive Analysis

The UAE Biomaterials in Healthcare Market size is at around $781 Mn in 2022 and is projected to reach $2260 Mn in 2030, exhibiting a CAGR of 14.20% during the forecast period. The UAE currently spends $2,996.36 per person on healthcare, up from $2,843.78 in 2018. In 2021, healthcare will account for 5.5% of the UAE's GDP. In 2022, the UAE's male and female life expectancy rates are 78.21 and 80.99 years, respectively.

In UAE, by lowering complications and enhancing therapy efficacy, biomaterials can enhance patient outcomes. By lowering the need for additional surgeries, hospital stays, and other expensive interventions, biomaterials can aid in lowering healthcare expenses. By offering more effective treatments for a broader range of medical conditions, biomaterials can aid in lowering the cost of healthcare. Through the alleviation of discomfort, the restoration of function, and enhancement of general health and wellbeing, biomaterials can enhance quality of life. Biomaterials development and production have the potential to boost the economy and add new employment, making them a vital component of UAE's healthcare sector. To build scaffolds for tissue engineering, which can be used to produce replacement organs and tissues, biomaterials are used. The efficacy of treatments is increased by using biomaterials to build drug delivery devices that can release drugs over a predetermined time period.

uae-biomaterials-in-healthcare-market

Market Dynamics

Market Growth Drivers

The demand for biomaterials, is rising in UAE as the population increases. As a result, there are now chances for manufacturers of biomaterials to diversify their product lines and grow their market share. UAE's expanding middle class and expanding economy have increased demand for healthcare services, including biomaterials and medical equipment. The market for biomaterials is anticipated to expand as a result of this trend in the years to come. The demand for biomaterials to address age-related illnesses like osteoarthritis, spinal problems, and cardiovascular disease is rising in UAE as the population gets older. The UAE government is devoted to fostering the biomaterials market's expansion. This includes financial support for research and development, tax breaks, and regulatory assistance, all of which contribute to the development and growth of the UAE biomaterial healthcare market.

Market Restraints

Significant well-known producers of biomaterials can be found in the UAE, along with numerous foreign firms doing business in the area. It can be difficult for new entrants to acquire market share in this highly competitive environment. It may be difficult for biomaterials producers to find and keep talented employees because of the shortage of qualified workers in the UAE's healthcare sector. Longer lead times and increased labour expenses are possible consequences of this.

Competitive Landscape

Key Players

Julphar (UAE)
Al Majaz Medical Equipment (UAE)
Mena Medical Supplies (UAE)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Notable Recent Deals

2021: The UK-based Tissue Regenix Group, an expert in regenerative medicine, has partnered with Mena Medical Supplies in UAE to distribute its OrthoPure XT decellularized human tendon allografts for use in orthopaedic procedures throughout the UAE and the larger MENA area.

Healthcare Policies and Regulatory Landscape

The Emirates Authority for Standardization and Metrology (ESMA), which is in charge of overseeing the country's extensive biomaterials regulatory structure. Before their devices can be marketed and sold in the UAE, manufacturers must acquire a Conformity Assessment Certificate (CAC), which applies to all varieties of medical devices, including biomaterials. The Health Authority Abu Dhabi (HAAD) is in charge of registering and approving medical devices, including biomaterials, in the emirate and is the governing body for healthcare in Abu Dhabi. In order to guarantee compliance with rules, the HAAD also establishes standards for the reliability and safety of medical devices and performs inspections of the facilities that manufacture them. The Dubai Health Authority (DHA) is in charge of registering and approving biomaterials in the emirate and is Dubai's governing body for healthcare. The DHA also establishes requirements for the performance and security of medical devices and performs inspections of manufacturing sites to verify adherence to rules.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the UAE market in 2019. The growing geriatric population UAEly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.